Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study) - Cécile Cieuta-Walti, Klaus Langohr, Claire Rakic, Ma Ángeles López-Vílchez, Julián Lirio, Domingo González-Lamuño Leguina, Teresa Bermejo González, Maria Rimblas Roure, Florence Lacaille, Aimé Ravel, Clotilde Mircher, Hervé Walti, Nathalie Janel, Marilyne Lévy, Silvia Sacco - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Elsevier, Genetics in Medicine, 10(24), p. 2004-2013, 2022

DOI: 10.1016/j.gim.2022.06.011

Links

Tools

Export citation

Search in Google Scholar

Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)

Journal article published in 2022 by Cécile Cieuta-Walti, Klaus Langohr, Claire Rakic, Ma Ángeles López-Vílchez, Julián Lirio, Domingo González-Lamuño Leguina, Teresa Bermejo González, Maria Rimblas Roure, Florence Lacaille, Aimé Ravel, Clotilde Mircher, Hervé Walti, Nathalie Janel, Marilyne Lévy, Silvia Sacco and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Red circle

Postprint: archiving forbidden

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO